PetMedix Raises $37M in Series B Funding

PetMedix, a Cambridge UK-based animal health company, raised $37M in Series B funding. The round was led by Tencent and Kyoritsu Holdings with participation from Digitalis Ventures, Parkwalk Advisors and Cambridge Innovation Capital. The company intends to use the funds to advance its innovative pipeline through clinical development. Led by Tom Weaver, CEO,...

Read Full Story
Allan Bradley Cambridge Innovation Capital Dave Lowery PetMedix Tencent Tom Weaver

Top News


Tonga covered in thick layer of ash, photos after volcano eruption and tsunami show


Blinken to travel to Ukraine amid tensions with Russia


Load app to read more comments